Kercheville Advisors, LLC Immunity Bio, Inc. Transaction History
Kercheville Advisors, LLC
- $288 Million
- Q2 2025
A detailed history of Kercheville Advisors, LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Kercheville Advisors, LLC holds 100,500 shares of IBRX stock, worth $248,235. This represents 0.09% of its overall portfolio holdings.
Number of Shares
100,500Holding current value
$248,235% of portfolio
0.09%Shares
1 transactions
Others Institutions Holding IBRX
# of Institutions
264Shares Held
89.3MCall Options Held
1.2MPut Options Held
1.71M-
Vanguard Group Inc Valley Forge, PA21.8MShares$53.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$28.2 Million0.0% of portfolio
-
State Street Corp Boston, MA7.62MShares$18.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA5.78MShares$14.3 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA3.45MShares$8.51 Million0.05% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $989M
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...